Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 24 January 2008. doi:10.1136/adc.2007.120691
Archives of Disease in Childhood - Fetal and Neonatal Edition 2008;93:F257-F260
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2007.120691v1
93/4/F257    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Farombi-Oghuvbu, I
Right arrow Articles by Corcoran, J D
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farombi-Oghuvbu, I
Right arrow Articles by Corcoran, J D
Topic Collections
Right arrowRelevant Article

ORIGINAL ARTICLES

N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus

I Farombi-Oghuvbu1, T Matthews1, P D Mayne2, H Guerin2, J D Corcoran1

1 Department of Neonatal Paediatrics, Rotunda Hospital, Dublin, Ireland
2 Department of Clinical Biochemistry, Rotunda Hospital, Dublin, Ireland

Correspondence to:
Dr I Farombi-Oghuvbu, Department of Neonatal Paediatrics, Rotunda Hospital, Parnell Street, Dublin 1, Ireland; ibuky{at}hotmail.com

Background: B-type natriuretic peptide (BNP) is a marker for ventricular dysfunction secreted as a pre-prohormone, pro-B-type natriuretic peptide (proBNP), and cleaved into BNP and a biologically inactive fragment, N-terminal pro-B-type natriuretic peptide (NT-proBNP). Little is known about the clinical usefulness of NT-proBNP in preterm infants.

Objective: To evaluate the usefulness of plasma NT-proBNP in diagnosing haemodynamically significant patent ductus arteriosus (hsPDA) in neonates and examine some factors that might affect this.

Methods: Infants born at <34 weeks’ gestational age (GA) and <2 kg birth weight (BW) were prospectively enrolled within 6–12 hours of birth. Plasma NT-proBNP levels were measured on days 1, 3, 5 and 10 with simultaneous echocardiography done to detect hsPDA and assess ventricular function. Significant PDA was diagnosed by large ductal flow with left to right shunt on colour Doppler, measuring >1.6 mm on two-dimensional echocardiography, along with clinical features of PDA.

Results: Forty-nine infants were analysed. Median GA was 30 weeks (range 24–33) and median BW 1220 g (range 550–1950). Eighteen infants with hsPDA had higher day 3 plasma NT-proBNP values (median 32 907 pg/ml; range 11 396–127 155) (p<0.001) than controls (median 3147 pg/ml; range 521–10 343). Infants who developed sepsis had higher day 10 plasma NT-proBNP levels. Area under receiver operator characteristic curve for detection of hsPDA, by day 3 NT-proBNP value, was significant 0.978 (95% CI 0.930 to 1.026). NT-proBNP was predictive of hsPDA (sensitivity 100%; specificity 95%) at a cut-off value of 11 395 pg/ml.

Conclusion: Plasma NT-proBNP level on day 3 is a good marker for hsPDA in preterm infants. Serial measurements of NT-proBNP may be useful in assessing the clinical course of PDA.



Relevant Article

Fantoms
Martin Ward Platt
Arch. Dis. Child. Fetal Neonatal Ed. 2008 93: F251. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
NeoReviewsHome page
J. Gien
Controversies in the Management of Patent Ductus Arteriosus
NeoReviews, October 1, 2008; 9(10): e477 - e482.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health